STOCK TITAN

[Form 4] Life360, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Life360, Inc. (LIF) Form 4: This filing reports insider transactions by John Burke Russell, identified as the companys Chief Financial Officer. On 08/26/2025 the reporting person sold 16,287 shares of common stock at a weighted-average price of $90.42 per share (individual trade prices ranged from $90.07 to $90.72). After the sale, the filing shows 63,030 shares beneficially owned indirectly, held by the Russell John Burke Revocable Trust. The filing also notes a prior transfer of 79,317 directly held shares to that trust, which the filer states was exempt from Section 16 under Rule 16a-13. Additionally, 111,231 restricted stock units remain recorded as contingent rights to receive common stock upon vesting. The form is signed by Allison Chang, Attorney-in-Fact, dated 08/28/2025.

Life360, Inc. (LIF) Modulo 4: Questa comunicazione riporta operazioni interne effettuate da John Burke Russell, indicato come Chief Financial Officer della società. In data 26/08/2025 la persona segnalante ha venduto 16.287 azioni ordinarie a un prezzo medio ponderato di $90,42 per azione (i prezzi delle singole operazioni variavano da $90,07 a $90,72). Dopo la vendita, il documento riporta il possesso indiretto di 63.030 azioni detenute dal Russell John Burke Revocable Trust. Si segnala inoltre un precedente trasferimento di 79.317 azioni detenute direttamente verso tale trust, che il dichiarante indica essere stato esente dalla Sezione 16 ai sensi della Regola 16a-13. Inoltre, restano registrate 111.231 unità di azioni vincolate (restricted stock units) come diritti condizionati a ricevere azioni ordinarie al momento della maturazione. Il modulo è firmato da Allison Chang, procuratrice (Attorney-in-Fact), in data 28/08/2025.

Life360, Inc. (LIF) Formulario 4: Este informe comunica operaciones de insiders realizadas por John Burke Russell, identificado como el Director Financiero de la compañía. El 26/08/2025 la persona informante vendió 16.287 acciones ordinarias a un precio medio ponderado de $90,42 por acción (los precios de las operaciones individuales oscilaron entre $90,07 y $90,72). Tras la venta, el formulario muestra la titularidad beneficiaria indirecta de 63.030 acciones, mantenidas por el Russell John Burke Revocable Trust. El documento también registra una transferencia previa de 79.317 acciones mantenidas directamente al referido trust, que el declarante señala estuvo exenta de la Sección 16 conforme a la Regla 16a-13. Adicionalmente, quedan registradas 111.231 unidades restringidas de acciones (restricted stock units) como derechos contingentes a recibir acciones ordinarias al convertirse en efectivas. El formulario está firmado por Allison Chang, apoderada (Attorney-in-Fact), con fecha 28/08/2025.

Life360, Inc. (LIF) 양식 4: 본 제출서류는 회사의 최고재무책임자(Chief Financial Officer)로 표시된 John Burke Russell의 내부자 거래를 보고합니다. 2025-08-26에 보고자는 보통주 16,287주를 주당 가중평균 가격 $90.42에 매도했습니다(개별 거래 가격은 $90.07에서 $90.72 사이). 매도 후 제출서류에는 Russell John Burke Revocable Trust가 간접적으로 보유한 63,030주가 이익귀속된 것으로 기재되어 있습니다. 또한 제출서류는 이전에 직접 보유하던 79,317주를 해당 트러스트로 이전했음을 기록하고 있으며, 제출인은 이 이전이 규칙 16a-13에 따른 섹션 16의 면제 대상이었다고 명시했습니다. 더불어 111,231개의 제한부 주식수익권(restricted stock units)은 가득 시점에 보통주를 수령할 조건부 권리로 계속 기재되어 있습니다. 양식은 법정대리인(Attorney-in-Fact) Allison Chang이 서명했으며, 날짜는 2025-08-28입니다.

Life360, Inc. (LIF) Formulaire 4 : Ce dépôt rapporte des opérations d'initiés effectuées par John Burke Russell, identifié comme le Directeur financier de la société. Le 26/08/2025, la personne déclarant a vendu 16 287 actions ordinaires à un prix moyen pondéré de 90,42 $ par action (les prix des transactions individuelles variaient de 90,07 $ à 90,72 $). Après la vente, le document indique la détention bénéficiaire indirecte de 63 030 actions, détenues par le Russell John Burke Revocable Trust. Le dépôt signale également un transfert antérieur de 79 317 actions détenues directement vers ce trust, que le déclarant indique comme exonéré de la Section 16 en vertu de la Règle 16a-13. De plus, 111 231 unités d'actions restreintes (restricted stock units) restent enregistrées comme droits conditionnels à recevoir des actions ordinaires au moment de leur acquisition. Le formulaire est signé par Allison Chang, mandataire (Attorney-in-Fact), daté du 28/08/2025.

Life360, Inc. (LIF) Formular 4: Diese Meldung berichtet über Insider-Transaktionen von John Burke Russell, der als Chief Financial Officer des Unternehmens angegeben ist. Am 26.08.2025 verkaufte die meldende Person 16.287 Stammaktien zu einem gewichteten Durchschnittspreis von $90,42 je Aktie (Einzelhandelspreise lagen zwischen $90,07 und $90,72). Nach dem Verkauf weist die Meldung einen indirekten wirtschaftlichen Besitz von 63.030 Aktien aus, gehalten vom Russell John Burke Revocable Trust. Die Meldung vermerkt zudem eine frühere Übertragung von 79.317 direkt gehaltenen Aktien an diesen Trust, die der Melder als von Abschnitt 16 nach Regel 16a-13 ausgenommen angibt. Zusätzlich bleiben 111.231 Restricted Stock Units als bedingte Ansprüche auf Erhalt von Stammaktien bei Vesting verzeichnet. Das Formular ist von Allison Chang, Attorney-in-Fact, unterzeichnet und datiert 28.08.2025.

Positive
  • Timely disclosure of insider sale and transfers via Form 4
  • Detailed pricing provided (weighted-average $90.42 and price range $90.07–$90.72)
  • Clear RSU disclosure showing 111,231 contingent units outstanding
Negative
  • Insider sale of 16,287 shares by the CFO (reduces direct holdings)
  • Direct-to-trust transfer of 79,317 shares reduces directly held shares

Insights

TL;DR: CFO sold a modest holding, transferred direct shares into a revocable trust, and holds significant unvested RSUs.

The sale of 16,287 shares at a weighted-average price of $90.42 is explicitly reported and the filing documents a prior transfer of 79,317 directly held shares into a revocable trust under Rule 16a-13 exemption. Post-transaction indirect beneficial ownership is 63,030 shares and 111,231 RSUs remain outstanding as contingent rights. These are standard Section 16 disclosures; the filing provides granular price range details and an undertaking to provide trade-level breakouts if requested.

TL;DR: Transaction is routine insider disclosure showing sale and trust transfer; no regulatory noncompliance disclosed.

The Form 4 documents both a sale and an indirect ownership structure via a revocable trust, with the filer asserting the trust transfer was exempt under Rule 16a-13. The filing is signed by an attorney-in-fact and includes the explanatory note about weighted-average pricing and RSU counts. The report contains no statements of litigation, policy breaches, or omitted material facts within the filing text.

Life360, Inc. (LIF) Modulo 4: Questa comunicazione riporta operazioni interne effettuate da John Burke Russell, indicato come Chief Financial Officer della società. In data 26/08/2025 la persona segnalante ha venduto 16.287 azioni ordinarie a un prezzo medio ponderato di $90,42 per azione (i prezzi delle singole operazioni variavano da $90,07 a $90,72). Dopo la vendita, il documento riporta il possesso indiretto di 63.030 azioni detenute dal Russell John Burke Revocable Trust. Si segnala inoltre un precedente trasferimento di 79.317 azioni detenute direttamente verso tale trust, che il dichiarante indica essere stato esente dalla Sezione 16 ai sensi della Regola 16a-13. Inoltre, restano registrate 111.231 unità di azioni vincolate (restricted stock units) come diritti condizionati a ricevere azioni ordinarie al momento della maturazione. Il modulo è firmato da Allison Chang, procuratrice (Attorney-in-Fact), in data 28/08/2025.

Life360, Inc. (LIF) Formulario 4: Este informe comunica operaciones de insiders realizadas por John Burke Russell, identificado como el Director Financiero de la compañía. El 26/08/2025 la persona informante vendió 16.287 acciones ordinarias a un precio medio ponderado de $90,42 por acción (los precios de las operaciones individuales oscilaron entre $90,07 y $90,72). Tras la venta, el formulario muestra la titularidad beneficiaria indirecta de 63.030 acciones, mantenidas por el Russell John Burke Revocable Trust. El documento también registra una transferencia previa de 79.317 acciones mantenidas directamente al referido trust, que el declarante señala estuvo exenta de la Sección 16 conforme a la Regla 16a-13. Adicionalmente, quedan registradas 111.231 unidades restringidas de acciones (restricted stock units) como derechos contingentes a recibir acciones ordinarias al convertirse en efectivas. El formulario está firmado por Allison Chang, apoderada (Attorney-in-Fact), con fecha 28/08/2025.

Life360, Inc. (LIF) 양식 4: 본 제출서류는 회사의 최고재무책임자(Chief Financial Officer)로 표시된 John Burke Russell의 내부자 거래를 보고합니다. 2025-08-26에 보고자는 보통주 16,287주를 주당 가중평균 가격 $90.42에 매도했습니다(개별 거래 가격은 $90.07에서 $90.72 사이). 매도 후 제출서류에는 Russell John Burke Revocable Trust가 간접적으로 보유한 63,030주가 이익귀속된 것으로 기재되어 있습니다. 또한 제출서류는 이전에 직접 보유하던 79,317주를 해당 트러스트로 이전했음을 기록하고 있으며, 제출인은 이 이전이 규칙 16a-13에 따른 섹션 16의 면제 대상이었다고 명시했습니다. 더불어 111,231개의 제한부 주식수익권(restricted stock units)은 가득 시점에 보통주를 수령할 조건부 권리로 계속 기재되어 있습니다. 양식은 법정대리인(Attorney-in-Fact) Allison Chang이 서명했으며, 날짜는 2025-08-28입니다.

Life360, Inc. (LIF) Formulaire 4 : Ce dépôt rapporte des opérations d'initiés effectuées par John Burke Russell, identifié comme le Directeur financier de la société. Le 26/08/2025, la personne déclarant a vendu 16 287 actions ordinaires à un prix moyen pondéré de 90,42 $ par action (les prix des transactions individuelles variaient de 90,07 $ à 90,72 $). Après la vente, le document indique la détention bénéficiaire indirecte de 63 030 actions, détenues par le Russell John Burke Revocable Trust. Le dépôt signale également un transfert antérieur de 79 317 actions détenues directement vers ce trust, que le déclarant indique comme exonéré de la Section 16 en vertu de la Règle 16a-13. De plus, 111 231 unités d'actions restreintes (restricted stock units) restent enregistrées comme droits conditionnels à recevoir des actions ordinaires au moment de leur acquisition. Le formulaire est signé par Allison Chang, mandataire (Attorney-in-Fact), daté du 28/08/2025.

Life360, Inc. (LIF) Formular 4: Diese Meldung berichtet über Insider-Transaktionen von John Burke Russell, der als Chief Financial Officer des Unternehmens angegeben ist. Am 26.08.2025 verkaufte die meldende Person 16.287 Stammaktien zu einem gewichteten Durchschnittspreis von $90,42 je Aktie (Einzelhandelspreise lagen zwischen $90,07 und $90,72). Nach dem Verkauf weist die Meldung einen indirekten wirtschaftlichen Besitz von 63.030 Aktien aus, gehalten vom Russell John Burke Revocable Trust. Die Meldung vermerkt zudem eine frühere Übertragung von 79.317 direkt gehaltenen Aktien an diesen Trust, die der Melder als von Abschnitt 16 nach Regel 16a-13 ausgenommen angibt. Zusätzlich bleiben 111.231 Restricted Stock Units als bedingte Ansprüche auf Erhalt von Stammaktien bei Vesting verzeichnet. Das Formular ist von Allison Chang, Attorney-in-Fact, unterzeichnet und datiert 28.08.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burke Russell John

(Last) (First) (Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/26/2025 S 16,287 D $90.42(1) 63,030(2) I Held by the Russell John Burke Revocable Trust
Common stock 111,231(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.07 to $90.72, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
2. The Reporting Person transferred 79,317 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
3. Reflects 111,231 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Remarks:
/s/ Allison Chang, Attorney-in-Fact 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Life360 (LIF) disclose on this Form 4?

The CFO sold 16,287 shares on 08/26/2025 at a weighted-average price of $90.42 and transferred 79,317 directly held shares into a revocable trust.

How many shares does the reporting person beneficially own after the reported transactions?

The filing reports 63,030 shares beneficially owned indirectly after the transactions.

What price range were the shares sold at in the LIF Form 4?

The shares were sold in multiple transactions at prices ranging from $90.07 to $90.72 per share; weighted-average price $90.42.

Does the filing disclose any unvested equity awards for the reporting person?

Yes. The filing reflects 111,231 restricted stock units that represent contingent rights to receive common stock upon vesting.

Were the transfers to the revocable trust reported as exempt from Section 16 requirements?

Yes. The filer states the transfer of 79,317 directly held shares to the Russell John Burke Revocable Trust was exempt under Rule 16a-13.
Life360 Inc

NASDAQ:LIF

LIF Rankings

LIF Latest News

LIF Latest SEC Filings

LIF Stock Data

7.06B
61.50M
2.25%
26.78%
4.63%
Software - Application
Services-computer Processing & Data Preparation
Link
United States
SAN MATEO